About the Company

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, MS and endocrinology. EMD Serono is also a leader in fertility treatments. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with more than 1000 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts.

Description

The Oncology-Immunotherapy program at EMD Serono, is seeking a new leader for its Molecular Immunology Program with a focus on molecular/cellular immunology for its translational research program in cancer immunotherapy. This position will place emphasis on the development of novel strategies for cancer therapeutics. The applicant should have expertise in immune and tumor cell interactions and understand mechanisms of immune cell activation at both cellular, molecular and signaling levels. The incumbent will implement strategies to enhance immunotherapeutic modalities as well as the vaccine-mediated approaches for cancer therapy. The incumbent will have the opportunity to supervise research associates, group leaders and support staff, and will interact with other scientists and peers in the program.

Additional responsibilities include:

• Contributing to the development and implementation of the oncology research strategy with emphasis on the immunological mechanisms of actions for candidate drugs.
• Directing and leading research of molecular immunology groups with an emphasis on the design of pre-clinical studies
• Maintaining an internal research program in molecular immunology that continuously upgrades and sustains effective use of current technology to address immunological questions at pre-clinical and clinical levels.
• Developing ranges of appropriate molecular/immunological end points in close interaction with the internal immunotherapy groups translational, cellular and applied immunology.
• Driving the development of innovative approaches in molecular immunology to better meet the goals of discovery and development projects.
• Keeping an active bench presence(at least 30% of the time) while leading various projects.